x

NAFDAC approves emergency use of Johnson & Johnson COVID-19 vaccine

The National Agency for Food and Drug Administration and Control (NAFDAC) on Tuesday gave Janssen (Johnson and Johnson) COVID-19 vaccine the nod for conditional emergency use for Nigerians from 18 years

Director-General of the agency, Prof. Mojisola Adeyeye, made this known in a statement in Abuja.

She said: “After a thorough evaluation, the NAFDAC vaccine committee concluded that the data on the vaccine were robust and met criteria for efficacy, safety and quality.

“Thee data also show that the vaccine’s known and potential benefits outweigh its known and potential risks thereby supporting the manufacturer’s recommended use. Janssen COVID-19 Vaccine is the third vaccine recommended in Nigeria for preventing COVID-19.

“The Janssen COVID-19 vaccine is administered as a single dose. Results from a clinical trial involving people in the United States, South Africa and Latin American countries found that Janssen COVID-19 Vaccine was effective at preventing COVID-19 in people from 18 years of age.

“The Phase III clinical trial involved over 44,000 people. Half received a single dose of the vaccine and half were given placebo (a dummy injection). People did not know if they had been given Janssen COVID-19 Vaccine or placebo.

“The trial found a 67 percent reduction in the number of symptomatic COVID-19 cases after 2 weeks in people who received Janssen COVID-19 Vaccine.

“The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects were mild to moderate in severity and lasted 1-2 days.”

On safety of the vaccine, the NAFDAC boss added: “In line with the NAFDAC’s Pharmacovigilance and safety monitoring plan for COVID-19 vaccines, Janssen COVID-19 vaccine will be closely monitored and subject to several activities that apply specifically to COVID-19 vaccines.

“Manufacturers are required to provide monthly safety reports in addition to the regular updates generated by NAFDAC activities. Janssen COVID-19 Vaccine works by preparing the body to defend itself against COVID-19.

“Unopened vaccine vials can be stored and/or transported frozen at -25°C to – 15°C for up to 24 months and 3 months when stored at 2 to 8°C.

“The Ministry of Health and National Primary Health Care Development Agency will announce when the vaccine becomes available for use in Nigeria.”

Hot this week

Wike Seeks Politics of Transformational Governance in Africa

By Joyce Remi-BabayejuThe Minister of the Federal Capital...

Consumer Protection Commission charges against food adulteration

By Israel Adamu, JosThe Federal Competition and Consumer...

KOSIEC Releases Timetable for 2026 Kogi Local Government Elections

By Noah Ocheni, LokojaThe Kogi State Independent...

BAVCCA urges Nigerians to defend Dangote Refinery

President of the Bloggers and Vloggers, Content Creators Association...

INSPIRATION: The Family: The Forgotten Powerhouse of Civilization

By Mary EwaFamily — the smallest yet most powerful...

INSPIRATION: Seeing Myself in the Light of Now

By Mary EwaTechnology is the wealth of the twenty-first...

PenCom mulls reintroduction of gratuity as pension assets hit N25trillion

By Ogenyi Ogenyi, UyoThe National Pension Commission, PenCom, has...

Security Operatives Question NDDC MD Over Alleged Coup Financing

By our correspondentThere is palpable tension at the headquarters...

ALSTDI Commends President Tinubu for Extending Adebomehin’s Tenure, Hails Progress in Geospatial Intelligence and National Mapping Reforms

….Says extension reflects confidence in performance and continuity….Urges Surveyor-General...

ALSTDI Commends Tinubu for Extending Adebomehin’s Tenure, Praises Geospatial and Mapping Reforms

….Says extension reflects confidence in performance and continuity….Urges Surveyor-General...

The Global Governance Initiative and the Quest for a Multipolar World

By Prof. Udenta O. UdentaThe world is changing, and...

Related Articles

Popular Categories

spot_imgspot_img